Home / Tag Archives: (NASDAQ:ARRY)

Tag Archives: (NASDAQ:ARRY)

May, 2017

  • 11 May

    Money-making stocks you should surely buy: Array BioPharma Inc. (ARRY)

    The top gainer with a security that increased in price during today’s trading was Array BioPharma Inc. (NASDAQ:ARRY). Array BioPharma Inc. had a higher price at the close than it did at the open. The company holds a market cap of 1.5B with a P/E of *TBA indicating whether its share price …

  • 5 May

    Assessing the stock market for: Array BioPharma Inc. (NASDAQ: ARRY)

    Array BioPharma Inc. (NASDAQ: ARRY), is in the industry Biotechnology. Based in USA, Array BioPharma Inc. has a market cap of 1.25 B. Therefore, Array BioPharma Inc. is a large market cap stock. Today it is currently trading at 7.09 (-3.47%), with an average volume 4088.42, its volume today is …

  • 5 May

    Assessing the stock market for: Array BioPharma Inc. (NASDAQ: ARRY)

    Array BioPharma Inc. (NASDAQ: ARRY), is in the industry Biotechnology. Based in USA, Array BioPharma Inc. has a market cap of 1.25 B. Therefore, Array BioPharma Inc. is a large market cap stock. Today it is currently trading at 7.09 (-3.47%), with an average volume 4088.42, its volume today is …

  • 4 May

    Evaluating today’s stock market for: Array BioPharma Inc. (NASDAQ:ARRY)

    With its total market value of the company’s outstanding shares, the market cap of Array BioPharma Inc. (NASDAQ:ARRY) in today’s trade was 1.31 B. Array BioPharma Inc. traded at a P/E ratio of *TBA, suggesting the potentiality of a higher growth in the future. By maintaining an average market P/E ratio …

  • 3 May

    Formidable stocks that ruled today’s share market: Array BioPharma Inc. (NASDAQ: ARRY)

    The market cap of 1.25 B for Array BioPharma Inc. in today’s market indicated its current strength, making the company’s shares a lucrative one. The company’s existing price is 7.9 with a change in volume of 2669268. Array BioPharma Inc.’s target price was set to 11.25 with an IPO date at 11/30/2000. The Return on Equity …